{"nct_id":"NCT06662786","title":"A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer","status":"RECRUITING","status_verified_date":"2025-09","start_date":"2024-10-18","start_date_type":"ACTUAL","primary_completion_date":"2028-12-15","primary_completion_date_type":"ESTIMATED","completion_date":"2032-12-15","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["JNJ"]}